Tolemy Bio | $1,643,411 | (May 13, 2026)
Basata | $21,000,000 | (May 13, 2026)
Corvera (YC W26) | $4,200,000 | (May 13, 2026)
Deep Apple Therapeutics
United States
- San Francisco Bay Area
- 18/12/2023
- Series A
- $52,000,000
In a vast, unexplored virtual chemical space, Deep Apple Therapeutics moves with unprecedented speed to discover novel small molecules for high-value targets. Deep Apple combines ensemble cryo-EM to explore receptor conformations; deep learning; and the docking of multi-billion compound libraries generated using the company's proprietary Orchard.ai™ algorithm. Deep Apple's deep learning discovery engine is built upon founder expertise in computational modeling, protein and target structure determination, large-scale molecular docking, and the elucidation of protein dynamics and conformational transitions. This structure-based, machine-learning driven drug design approach enables the company to rapidly advance novel candidates addressing well-validated targets in inflammatory, metabolic, and endocrine diseases. For more information, visit deepappletx.com.
- Industry Biotechnology Research
- Website https://deepappletx.com/
- LinkedIn https://www.linkedin.com/company/deep-apple-therapeutics/about/
4AM | $4,000,000 | (May 13, 2026)
Ciridae | $20,000,000 | (May 13, 2026)
Sedivention - Freezing the hunger feeling | $3,402,541 | (May 13, 2026)
Meatly | $14,074,996 | (May 13, 2026)
NanoStruct GmbH | $3,050,853 | (May 13, 2026)
Adfin | $18,000,000 | (May 13, 2026)
Boundary | $2,000,000 | (May 13, 2026)
Knit Health | $11,600,000 | (May 13, 2026)